Wird geladen...
VEGF blockade enhances the antitumor effect of BRAF(V) (600E) inhibition
The development of resistance remains a major obstacle to long‐term disease control in cancer patients treated with targeted therapies. In BRAF‐mutant mouse models, we demonstrate that although targeted inhibition of either BRAF or VEGF initially suppresses the growth of BRAF‐mutant tumors, combined...
Gespeichert in:
Veröffentlicht in: | EMBO Mol Med |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
John Wiley and Sons Inc.
2016
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5286370/ https://ncbi.nlm.nih.gov/pubmed/27974353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201505774 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|